40 Participants Needed

Microplastics Exposure for Infant Development

(DIMPLE Trial)

Recruiting at 1 trial location
TL
CH
Overseen ByCharlotte Haslett
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to understand how microplastics (tiny plastic particles) affect mothers and infants. Researchers seek to identify microplastics in breast milk and infant stools and explore any link to infant growth and birth weight. Participants will provide samples and answer questions about their lifestyle and environmental exposures. The study is open to mothers living in Baltimore who are 1 or 3 months postpartum, have had a single birth, and plan to exclusively breastfeed for at least 6 months.

As an unphased trial, this study offers participants a unique opportunity to contribute to groundbreaking research on environmental health impacts.

Why are researchers excited about this trial?

Researchers are excited about this trial because it aims to uncover the developmental impacts of microplastics exposure in early life, something not fully understood yet. Unlike traditional studies that may focus on chemical exposure or nutritional factors, this trial zeroes in on micro and nano plastics, which are tiny particles that can be inhaled or ingested. By comparing mother-infant pairs from different areas within Baltimore, the trial seeks to determine how environmental factors and microplastics exposure during critical developmental stages might affect health outcomes. This research could pave the way for new public health guidelines to protect vulnerable populations from these emerging contaminants.

Who Is on the Research Team?

TL

Tanya L Alderete, PhD

Principal Investigator

Johns Hopkins Bloomberg School of Public Health

Are You a Good Fit for This Trial?

Inclusion Criteria

You identify with any gender identity or expression.
You have never given birth to a single child.
You are a mother who has given birth within the past four weeks or so.
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Clinical Visit

Participants complete questionnaires, provide biological specimens, and have anthropometric measures documented

1 day
1 visit (in-person)

Sample Collection

Participants collect and provide maternal and infant fecal samples, breast milk, and blood samples

1-2 weeks

Follow-up

Participants are monitored for safety and effectiveness after sample collection

4 weeks

What Are the Treatments Tested in This Trial?

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Group I: County Mother-Infant PairsExperimental Treatment1 Intervention
Group II: City Mother-Infant PairsExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Colorado, Boulder

Lead Sponsor

Trials
128
Recruited
29,600+

Johns Hopkins Bloomberg School of Public Health

Lead Sponsor

Trials
441
Recruited
2,157,000+

Sonoma Technology, Inc.

Collaborator

Trials
1
Recruited
40+

Emory University

Collaborator

Trials
1,735
Recruited
2,605,000+